Esmail Al-Ezzi, University of Toronto

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical Trial.
Targeted oncology · 2024
A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study.
Targeted oncology · 2022
A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS).
European journal of cancer (Oxford, England : 1990) · 2021

3 publications.

01

Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical Trial.

Salawu A, Malone ER, Al-Ezzi E, Genta S, Vornicova O, Wang L, Arones L, Phillips M, Lee J, Watson GA, Gupta AA, Abdul Razak AR

Targeted oncology20241 citations

DOI: 10.1007/s11523-024-01076-7 PMID: 38890222

02

A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study.

Salawu A, Hansen AR, Spreafico A, Al-Ezzi E, Webster S, Bedard PL, Doi J, Wang L, Siu LL, Abdul Razak AR

Targeted oncology202211 citations

DOI: 10.1007/s11523-022-00884-z PMID: 35635640

03

A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS).

Lewin J, Malone E, Al-Ezzi E, Fasih S, Pedersen P, Accardi S, Gupta A, Abdul Razak A

European journal of cancer (Oxford, England : 1990)202115 citations

DOI: 10.1016/j.ejca.2020.10.032 PMID: 33418486

Frequent collaborators

Department of Medicine
Institute of Medical Science
Biostatistics Division

Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Abdulazeez Salawu

Department of Medicine

2 shared papers, latest 2024

Abha Gupta

Institute of Medical Science

2 shared papers, latest 2024

Lisa Wang

Biostatistics Division

2 shared papers, latest 2024

Sofia Genta

Department of Medicine

1 shared papers, latest 2024

Anna Spreafico

Department of Medicine

1 shared papers, latest 2022

Lillian Siu

Department of Medicine

1 shared papers, latest 2022

Philippe Bedard

Department of Medicine

1 shared papers, latest 2022

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Al-Ezzi, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical Trial." (2024), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]